No Detail Found!

Evaluation of Hemochromatosis, Diagnosis and Management: Simple Literature Review

Author(s)
Abdulmalek Adel Aboulkhair Faculty of Medicine, Ibn Sina College,Jeddah, KSA,
Abdulrahman Ibn Almuataz Ezzi Faculty of Medicine, Ibn Sina College,Jeddah, KSA,
Tariek Abdullah Alharbi Faculty of Medicine, Ibn Sina College,Jeddah, KSA,
Ali Sultan Alzughbi Faculty of Medicine, Prince Sattam bin Abdulaziz University, Alkharj, KSA
Khalid Melih Marick Alshammari Faculty of Medicine, Ibn Sina College,Jeddah, KSA,
Sultan Musallam Alshammari Faculty of Medicine, Almaarefa University, Riyadh, KSA; Faculty of Medicine, Dar Aluloom University, Riyadh, KSA
Mansour Thallab Albagami Faculty of Medicine, Almaarefa University, Riyadh, KSA; Faculty of Medicine, Dar Aluloom University, Riyadh, KSA
Kawther Abdulla Alsadady Faculty of Medicine, Dar Aluloom University, Riyadh, KSA
Thamer Hamad M Alshahrani Faculty of Medicine, Almaarefa University, Riyadh, KSA.
Fatheya Ahmed Hussain Faculty of Medicine, King Abdulaziz University, Jeddah, KSA.
Anwar Mohammed Al Hadhari Faculty of Medicine, Northern Border University, Arar, KSA
Abstract
Background: Hemochromatosis is an autosomal recessive genetic disorder characterized by abnormal iron regulation in the body leading to excessive iron deposition in multiple organs. Most of the patients of hemochromatosis are presymptomatic or asymptomatic. Nevertheless, a minority of patients presents with severe complications. Objective: In this study, we aimed to discuss the published literature focused on diagnosing and managing hemochromatosis. Method: PubMed database was used for articles selection, and the following keys were used in the mesh ((“hemochromatosis”[Mesh]) and (“hemochromatosis management”[Mesh])). The articles' selection was based on the relevance to the topic as their primary endpoint. Conclusion: The stage of the disease and particularly the extent of iron overloading should be the parameters that are dependent on assessment and treatment. Phlebotomy is the mainstay of treatment in hemochromatosis cases. It improves insulin sensitivity, fatigue, and skin pigmentation. Initiating the phlebotomy before the development of liver cirrhosis has shown a significant decrease in morbidity and mortality rates. Iron chelation therapy can be an option when the hemoglobin of the patients cannot tolerate therapeutic phlebotomy.
Publication Details
Page(s) 101-103
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 11, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
Management Approach, Diagnosis, Hemochromatosis
References
Wahab N R,Al-dujaili M N,AL-Khirsani H A H A A .2020 .The impact of increased body weight on left ventricular diastolic function. J. Adv. Pharm. Edu. Res, 10(1) : 150-157.
Keyhanazar K. .2020 .Evaluation of oocyte changes around dankhoras and drinkers at different weeks in poultry farms of Mahabad. J. Adv. Pharm. Edu. Res, 10(1) : 90-95.
Waggiallah H A. Hepcidin .2020 .As an Iron Regulator and Inflammatory Mediator in Several Clinical Conditions: Narrative. Int. J. Pharm. Phytopharm. Res, 11(3) : 164-170.
Nourmohammadi E,Nedaeinia R,Goli M,Hosseini Teshnizi S,Sarkarizi H,Sarkarizi K,Nedaeinia M,Faraji H M .2018 .Novel application of Nanotechnology in drug and Gene delivery: emphasis on Liposomes. Int. J. Pharm. Phytopharm. Res, 8(6) : 81-91.
Sood R,Bakashi R,Hegade VS,Kelly SM . .Diagnosis and management of hereditary haemochromatosis. 2013 Jun, 1(611) : 331-2.
Bacon BR .2012 .Hemochromatosis: discovery of the HFE gene. Missouri medicine, 109(2) : 133-6.
Bacon BR,Adams PC,Kowdley KV,Powell LW,Tavill AS .2011 .Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md. , 54(1) : 328.
Phatak PD,Bonkovsky HL,Kowdley KV .2008 .Hereditary Hemochromatosis: Time for Targeted Screening. Annals of Internal Medicine, 149(4) : 200808190.
Adams PC,Reboussin DM,Barton JC,McLaren CE,Eckfeldt JH,McLaren GD,Dawkins FW,Acton RT,Harris EL,Gordeuk VR,Leiendecker-Foster C . .Hemochromatosis and iron-overload screening in a racially diverse population. 2005 Apr, 352(17) : 1769-78.
Allen KJ,Gurrin LC,Constantine CC,Osborne NJ,Delatycki MB,Nicoll AJ,McLaren CE,Bahlo M,Nisselle AE,Vulpe CD,Anderson GJ . .Iron-overload-related disease in HFE hereditary hemochromatosis. 2008 Jan, 17(3) : 221-30.
Adams P,Brissot P,Powell LW . .Part II. Expert Document. 2000 Sep, 8278(01) : 80874-6.
Zoller H,Henninger B .2016 .Pathogenesis, diagnosis and treatment of hemochromatosis. Digestive Diseases, 34(4) : 364-73.
Bardou-Jacquet E,Morcet J,Manet G,Lainé F,Perrin M,Jouanolle AM,Guyader D,Moirand R,Viel JF,Deugnier Y. .2014 .Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis. 2015 Mar, 10(3) : 682-9.
Wood MJ,Powell LW,Ramm GA . .Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. -11-122374., 1(9) : 4456-62.
De Gobbi M,Roetto A,Piperno A,Mariani R,Alberti F,Papanikolaou G,Politou M,Lockitch G,Girelli D,Fargion S,Cox TM .2002 .Natural history of juvenile haemochromatosis. British journal of haematology, 03509(4) : 2141-9.
Geller SA .2014 .Jan;5(1):7. Autopsy & case reports, 043 : .
Walton C,Kelly WF,Laing I,Bu'Lock DE I . .Endocrine abnormalities in idiopathic haemochromatosis. 1983 Jan, 1(1) : 99-110.
Kelly TM,EDWARDS CQ,MEIKLE AW . .Hypogonadism in hemochromatosis: reversal with iron depletion. 1984 Nov, 1(5) : 0003-32.
Adams PC,Barton JC. .2011 .A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. 2011 Aug, 02(2) : 453-8.
Adams PC,Speechley M,Barton JC,McLaren CE,McLaren GD,Eckfeldt JH . .Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study. Hepatology, 55(6) : 1722-6.
Yang Q,McDonnell SM,Khoury MJ,Cono J,Parrish RG . .Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. 1998 Dec, 1(11) : 2-199812011.
Niederau C,Strohmeyer G,Stremmel W. Epidemiology .1994 .clinical spectrum and prognosis of hemochromatosis. InProgress in Iron Research, : 31-302.
Schumacher HR . .Articular cartilage in the degenerative arthropathy of hemochromatosis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 25(12) : 1460-8.
Emery J,Rose P . .Hereditary haemochromatosis: never seen a case?. The British Journal of General Practice, 51(466) : 347.
Tavill AS .2001 .Diagnosis and management of hemochromatosis. Hepatology. 2001 May, 24783(5) : 1321-8.
Adams PC,Reboussin DM,Leiendecker-Foster C,Moses GC,McLaren GD,McLaren CE,Dawkins FW,Kasvosve I,Acton RT,Barton JC,Zaccaro D .2005 .Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101 168 participants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. 2005 Jun, 048371(6) : 1048-52.
Schmitt B,Golub RM,Green R . .Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. 2005 Oct, 4(7) : 200510040-36.
Pietrangelo A,Deugnier Y,Dooley J,Erhardt A,Zoller H,Safadi R. EASL .2010 .clinical practice guidelines for HFE hemochromatosis. 2010 Jul, 03(1) : 3-22.
0

Citations

0

Downloads

15

Views